I am doing my internship and currently posted in anaesthesia department so tell imp clinical points and also neet pg wise
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
anaesthesia important clinical points NEET PG 2024 2025 high yield topics
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have excellent textbook content. Let me compile the comprehensive, well-structured answer covering all major anaesthesia topics with NEET PG high-yield points.
Anaesthesia - Important Clinical Points + NEET PG High-Yield
1. THE ANAESTHETIC TRIAD (Most Tested Concept)
General anaesthesia = 3 components:
- Amnesia - loss of awareness/consciousness
- Analgesia - pain relief
- Muscle relaxation
NEET PG tip: "Triad of anaesthesia" is a classic one-liner. Unconsciousness + Analgesia + Muscle relaxation.
2. INTRAVENOUS INDUCTION AGENTS
| Agent | Key Feature | NEET PG Point |
|---|---|---|
| Propofol (di-isopropyl phenol) | Smooth induction, haemodynamic stability, anti-emetic, can be used for maintenance (TIVA) | Drug of choice for day-care surgery; causes propofol infusion syndrome on prolonged use; blunts laryngeal reflexes |
| Thiopentone (barbiturate) | Rapid induction, myocardial depression, lowers ICP | DOC for raised ICP / neurosurgical patients; causes histamine release; NOT used in porphyria |
| Etomidate (steroid derivative) | Best haemodynamic stability | DOC in cardiac compromised patients; causes adrenocortical suppression (inhibits 11-beta hydroxylase); causes myoclonus |
| Ketamine (phencyclidine derivative) | Dissociative anaesthesia, raises BP and HR, bronchodilator | DOC in asthmatics, hypovolaemic/shocked patients; causes emergence phenomena (hallucinations, nightmares) - prevented by midazolam; maintains laryngeal reflexes; raises ICP - AVOID in raised ICP |
| Midazolam | Anxiolytic, amnestic | Benzodiazepine - anterograde amnesia; reversed by flumazenil |
Important comparisons for NEET PG:
- Safest in cardiac disease: Etomidate
- Safest in bronchospasm/asthma: Ketamine
- Safest in day-care: Propofol
- Raises ICP: Ketamine (avoid in neuro)
- Lowers ICP: Thiopentone, Propofol
- Causes emergence delirium: Ketamine
- Contraindicated in porphyria: Thiopentone
3. INHALATIONAL AGENTS
| Agent | MAC | Key Point |
|---|---|---|
| Nitrous oxide (N2O) | 104% | Can never achieve full anaesthesia alone; used as carrier gas; second gas effect; causes diffusion hypoxia on withdrawal; avoid in pneumothorax, bowel obstruction, middle ear surgery |
| Halothane | 0.75% | Hepatotoxicity (halothane hepatitis); sensitizes myocardium to catecholamines (arrhythmias); good bronchodilator; obsolete in many countries |
| Isoflurane | 1.15% | Most widely used; pungent smell; causes coronary steal |
| Sevoflurane | 2% | Non-pungent - preferred for inhalational induction in children; produces Compound A (nephrotoxic at high concentrations) |
| Desflurane | 6% | Fastest recovery; pungent smell; causes tachycardia/hypertension on rapid increase; not used for induction |
MAC (Minimum Alveolar Concentration) - the alveolar concentration of an inhalational agent that prevents movement in 50% of patients in response to a surgical stimulus.
Factors decreasing MAC (less drug needed):
- Old age, hypothermia, pregnancy, hypotension, opioids, other CNS depressants, hyponatremia, anaemia
Factors increasing MAC (more drug needed):
- Hyperthermia, hyperthyroidism, chronic alcoholism, CNS stimulants, hypernatremia
4. NEUROMUSCULAR BLOCKING AGENTS (NMBAs)
Depolarizing (Non-competitive)
- Succinylcholine (Suxamethonium) - only drug in this class
- Fastest onset (60 sec), shortest duration (5-10 min)
- DOC for rapid sequence intubation (RSI)
- Side effects: hyperkalemia (dangerous in burns >24h, crush injury, spinal cord injury), bradycardia (more in children), raised IOP, raised ICP, raised intragastric pressure
- Malignant hyperthermia - triggered by succinylcholine + volatile agents (halothane, isoflurane)
- Metabolized by pseudocholinesterase (plasma cholinesterase)
- Scoline apnoea - prolonged apnoea due to pseudocholinesterase deficiency
- Reversed by: Fresh frozen plasma (provides pseudocholinesterase)
Non-Depolarizing (Competitive)
| Drug | Duration | Notes |
|---|---|---|
| Pancuronium | Long | Raises BP and HR (vagolytic) |
| Vecuronium | Intermediate | Cardiac neutral; biliary excretion |
| Rocuronium | Intermediate | Fastest onset among non-depolarizing; used for RSI when succinylcholine contraindicated |
| Atracurium | Intermediate | Histamine release; Hofmann elimination (not affected by renal/hepatic failure) - DOC in renal and hepatic failure |
| Cisatracurium | Intermediate | Like atracurium but no histamine release |
| Mivacurium | Short | Metabolized by pseudocholinesterase |
| d-Tubocurarine | Long | Oldest; causes hypotension |
Reversal of non-depolarizing NMBAs:
- Classic: Neostigmine + Atropine (neostigmine is anticholinesterase; atropine blocks muscarinic side effects)
- Modern: Sugammadex - reverses rocuronium and vecuronium specifically (cyclodextrin)
Train of Four (TOF) monitoring - 4 twitches at 2 Hz; ratio <0.9 indicates residual block
5. LOCAL ANAESTHETICS
| Drug | Class | Key Feature |
|---|---|---|
| Lignocaine (Lidocaine) | Amide | Most commonly used; class IB antiarrhythmic |
| Bupivacaine | Amide | Longest duration; most cardiotoxic (hard to resuscitate); used in spinal/epidural |
| Ropivacaine | Amide | Less cardiotoxic than bupivacaine; differential block (motor-sparing) |
| Procaine | Ester | Metabolized by pseudocholinesterase |
| Cocaine | Ester | Only LA that causes vasoconstriction (others cause vasodilation); used in nasal surgery |
| Tetracaine (Amethocaine) | Ester | Most potent, most toxic |
Mechanism: Block voltage-gated Na+ channels - bind to inner surface (use-dependent block)
Nerve fiber sensitivity (thinnest blocked first):
- B (autonomic preganglionic) > C (pain, temperature) > A-delta (fast pain) > A-gamma > A-beta > A-alpha (motor - last to be blocked)
- Clinically: sympathetic block > sensory block > motor block
Adding adrenaline (epinephrine) to LA:
- Prolongs duration of action
- Reduces systemic absorption and toxicity
- Contraindicated in: ring block (fingers, toes, penis, ear lobe), IV regional anaesthesia
Maximum safe doses (NEET favorite):
- Lignocaine plain: 3 mg/kg
- Lignocaine with adrenaline: 7 mg/kg
- Bupivacaine: 2 mg/kg
LA toxicity sequence:
- CNS first: perioral tingling, tinnitus, convulsions
- CVS later: arrhythmias, cardiovascular collapse
- Treatment of bupivacaine toxicity: Intralipid (20% lipid emulsion)
6. SPINAL vs EPIDURAL ANAESTHESIA
| Feature | Spinal | Epidural |
|---|---|---|
| Site | Subarachnoid space (L3-L4 or L4-L5 in adults) | Epidural space |
| Volume of LA | Small (2-4 mL) | Large (15-20 mL) |
| Onset | Rapid (2-5 min) | Slow (15-20 min) |
| Motor block | Dense | Can be partial/differential |
| Hypotension | More common | Less common |
| Catheter | No (single shot) | Yes (continuous possible) |
| Test dose | Not needed | Needed (adrenaline 15 mcg - tachycardia if intravascular) |
| Headache (PDPH) | More common (post-dural puncture) | Less common |
Post-dural puncture headache (PDPH):
- Frontal/occipital, worse on sitting/standing, better lying down
- Treated with: Blood patch (epidural blood patch - gold standard), hydration, caffeine, analgesics
Contraindications to spinal/epidural:
- Patient refusal
- Coagulopathy (INR >1.5, platelets <80,000)
- Local infection at site
- Raised ICP
- Severe AS/MS (relative)
High spinal (Total spinal): Emergency - hypotension, bradycardia, respiratory arrest - treat with vasopressors, IPPV
7. AIRWAY MANAGEMENT
Mallampati Classification (mouth open, tongue out, no phonation):
- Class I: Soft palate, fauces, uvula, pillars visible - Easy
- Class II: Soft palate, fauces, uvula visible
- Class III: Soft palate, base of uvula visible
- Class IV: Hard palate only visible - Difficult
Other predictors of difficult airway:
- Thyromental distance <6 cm (Patil's test)
- Mouth opening <3 cm
- Sternomental distance <12.5 cm
- Short neck, limited extension, buck teeth, large tongue
Airway devices:
- Oropharyngeal airway (Guedel): Unconscious patients, size = mouth corner to earlobe
- LMA (Laryngeal Mask Airway): Supraglottic; 1st gen (classic) vs 2nd gen (ProSeal, i-gel); no protection against aspiration with 1st gen
- Endotracheal tube (ETT): Gold standard for airway protection
- Size in children: (Age/4) + 4 mm internal diameter
- Depth of insertion: (Age/2) + 12 cm from teeth in children
RSI (Rapid Sequence Induction): Used when aspiration risk high (full stomach, GERD, obesity, pregnancy)
- Pre-oxygenate → IV induction (propofol/thiopentone) → Succinylcholine → Cricoid pressure (Sellick's manoeuvre) → intubate
8. MALIGNANT HYPERTHERMIA
- Trigger agents: Succinylcholine + volatile anaesthetics (halothane, isoflurane, sevoflurane, desflurane)
- Mechanism: Mutation in ryanodine receptor (RYR1) → uncontrolled Ca2+ release from SR → sustained muscle contraction
- Features: Hyperthermia (temp rise >2°C/hour), muscle rigidity, tachycardia, hyperkalemia, metabolic acidosis, raised creatine kinase, masseter spasm (first sign)
- Earliest sign: Rise in end-tidal CO2
- Treatment: Dantrolene (10 mg/kg, inhibits Ca2+ release from SR) - ONLY specific treatment; stop trigger agents, active cooling, correct metabolic derangements
- Genetic: Autosomal dominant
9. PREOPERATIVE ASSESSMENT (NPO/FASTING GUIDELINES)
ASA Physical Status Classification:
- ASA I: Normal healthy patient
- ASA II: Mild systemic disease
- ASA III: Severe systemic disease (limiting but not incapacitating)
- ASA IV: Severe systemic disease that is constant threat to life
- ASA V: Moribund (not expected to survive without surgery)
- ASA VI: Brain-dead for organ donation
Fasting guidelines ("2-4-6-8 rule"):
- 2 hours - clear fluids
- 4 hours - breast milk
- 6 hours - formula milk, light meal
- 8 hours - heavy/fatty meal
10. OPIOIDS IN ANAESTHESIA
| Drug | Key Feature |
|---|---|
| Morphine | Standard; histamine release; active metabolite (morphine-6-glucuronide) accumulates in renal failure |
| Fentanyl | 100x more potent than morphine; rapid onset; used for intraoperative analgesia |
| Remifentanil | Ultra-short acting; metabolized by non-specific esterases (not pseudocholinesterase); context-insensitive |
| Tramadol | Weak opioid + serotonin/NE reuptake inhibitor; less respiratory depression |
| Pethidine | Causes histamine release; metabolite norpethidine is neurotoxic; avoid in renal failure |
Opioid reversal: Naloxone (competitive antagonist at all opioid receptors); short-acting, may need repeat doses
Opioid side effects triad: Miosis (pinpoint pupils) + Respiratory depression + Constipation
11. MONITORED PARAMETERS
| Monitor | What It Measures |
|---|---|
| Pulse oximetry (SpO2) | Oxygen saturation; cannot detect CO poisoning or hyperoxia |
| Capnography (EtCO2) | Exhaled CO2; gold standard for confirming ETT placement; normal 35-45 mmHg |
| BIS (Bispectral Index) | Depth of anaesthesia; 0=flat EEG, 100=awake; target 40-60 during GA |
| Nerve stimulator (TOF) | Neuromuscular block monitoring |
| Arterial line | Beat-to-beat BP monitoring |
| CVP | Volume status assessment |
12. COMPLICATIONS - NEET PG FAVORITES
Aspiration pneumonitis (Mendelson's syndrome):
- Aspiration of gastric contents during induction
- Risk factors: Full stomach, emergency surgery, obesity, pregnancy
- pH <2.5 and volume >25 mL are the critical thresholds
- Prevention: RSI, cricoid pressure, H2 blockers, metoclopramide
Anaphylaxis under anaesthesia:
- Most common cause: Muscle relaxants (especially succinylcholine, atracurium)
- Treatment: Stop trigger → Adrenaline 0.5 mg IM → IV fluids → Hydrocortisone + Chlorphenamine
Awareness under anaesthesia:
- More common with TIVA, N2O-based techniques, Caesarean section
- Prevented by BIS monitoring and adequate doses
13. QUICK NEET PG ONE-LINERS
- Safest anaesthetic in porphyria - Propofol (NOT thiopentone)
- Drug causing scoline apnoea - Succinylcholine (pseudocholinesterase deficiency)
- Antagonist for benzodiazepines - Flumazenil
- Antagonist for opioids - Naloxone
- Neuroleptic anaesthesia - Droperidol + Fentanyl
- Neurolept analgesia - Droperidol + Fentanyl (without loss of consciousness)
- Balanced anaesthesia - Multiple drugs in small doses for each component of the triad
- Drug causing uterine relaxation - Halothane (avoid in PPH)
- Drug that DOES NOT cross placenta - Succinylcholine, Heparin (large molecules/charged)
- Guedel's stages of ether anaesthesia:
- Stage I: Analgesia
- Stage II: Excitement/Delirium (dangerous - laryngospasm)
- Stage III: Surgical anaesthesia (4 planes)
- Stage IV: Medullary depression (death)
- Most common cause of postoperative nausea/vomiting (PONV): Opioids; Best antiemetic - Ondansetron; Propofol has antiemetic properties
- Neuroaxial anaesthesia in an anticoagulated patient - wait 12h after prophylactic LMWH, 24h after therapeutic LMWH
14. PAIN MANAGEMENT
WHO Analgesic Ladder (3 steps):
- Non-opioid (Paracetamol, NSAIDs)
- Weak opioid (Tramadol, Codeine) + non-opioid
- Strong opioid (Morphine, Fentanyl) + non-opioid
Multimodal analgesia = combining different drug classes to reduce opioid requirements - current standard of care
PCA (Patient-Controlled Analgesia): Patient self-administers opioid boluses; requires lock-out interval
NEET PG WEIGHTAGE SUMMARY FOR ANAESTHESIA
Based on recent NEET PG 2025 analysis, Anaesthesia carries ~4 questions (2%) of the paper. The most commonly tested topics are:
- MAC values and factors affecting MAC
- Muscle relaxants - mechanism, reversal, complications (Malignant hyperthermia, scoline apnoea)
- Local anaesthetic pharmacology and toxicity
- Induction agents (especially ketamine - unique properties)
- Spinal vs epidural (Mallampati, complications)
- Airway management (RSI, failed airway)
- Monitoring - capnography, BIS, TOF
Focus heavily on ketamine, succinylcholine, malignant hyperthermia, local anaesthetic toxicity, and MAC - these appear almost every year.
Sources: Bailey and Love's Short Practice of Surgery 28th Edition (Chapter 23); Miller's Anesthesia 10th Edition
This is a shared conversation. Sign in to Orris to start your own chat.